Enzon Pharmaceuticals Equity 2024

Enzon Pharmaceuticals Aktienanalyse

What does Enzon Pharmaceuticals do?

Enzon Pharmaceuticals Inc. is an American biotechnology company that has been active since 1981. They specialize in researching, developing, and marketing innovative medicines. The company operates primarily in the United States but is also internationally known and active. Enzon Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Enzon Pharmaceuticals's Equity

Enzon Pharmaceuticals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Enzon Pharmaceuticals's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Enzon Pharmaceuticals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Enzon Pharmaceuticals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Enzon Pharmaceuticals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Enzon Pharmaceuticals stock

What is the equity of Enzon Pharmaceuticals this year?

Enzon Pharmaceuticals has equity of 45.99 M USD this year.

What was the equity of Enzon Pharmaceuticals compared to the previous year?

The equity of Enzon Pharmaceuticals has increased/decreased by 0.19% increased compared to the previous year.

What impact does a high equity have on investors of Enzon Pharmaceuticals?

A high equity is advantageous for investors of Enzon Pharmaceuticals as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Enzon Pharmaceuticals?

A low equity can be a risk for investors of Enzon Pharmaceuticals, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Enzon Pharmaceuticals affect the company?

An increase in equity of Enzon Pharmaceuticals can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Enzon Pharmaceuticals affect the company?

A reduction in equity of Enzon Pharmaceuticals can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Enzon Pharmaceuticals?

Some factors that can affect the equity of Enzon Pharmaceuticals include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Enzon Pharmaceuticals so important for investors?

The equity of Enzon Pharmaceuticals is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Enzon Pharmaceuticals take to change the equity?

To change equity, Enzon Pharmaceuticals can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Enzon Pharmaceuticals pay?

Over the past 12 months, Enzon Pharmaceuticals paid a dividend of 0.18 USD . This corresponds to a dividend yield of about 150 %. For the coming 12 months, Enzon Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Enzon Pharmaceuticals?

The current dividend yield of Enzon Pharmaceuticals is 150 %.

When does Enzon Pharmaceuticals pay dividends?

Enzon Pharmaceuticals pays a quarterly dividend. This is distributed in the months of January, October, March, October.

How secure is the dividend of Enzon Pharmaceuticals?

Enzon Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Enzon Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Enzon Pharmaceuticals located?

Enzon Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Enzon Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Enzon Pharmaceuticals from 10/15/2019 amounting to 0.12 USD, you needed to have the stock in your portfolio before the ex-date on 9/30/2019.

When did Enzon Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/15/2019.

What was the dividend of Enzon Pharmaceuticals in the year 2023?

In the year 2023, Enzon Pharmaceuticals distributed 0 USD as dividends.

In which currency does Enzon Pharmaceuticals pay out the dividend?

The dividends of Enzon Pharmaceuticals are distributed in USD.